Cisplatin and platinum analogues: recent advances
- PMID: 1457521
- DOI: 10.1097/00001622-199212000-00012
Cisplatin and platinum analogues: recent advances
Abstract
Cisplatin is a critically important antineoplastic agent employed in treating patients who have a broad spectrum of neoplasms. Resistance to this agent poses a serious clinical dilemma. The objective of this review is to summarize the principal mechanisms that contribute to cytotoxicity by this agent and underlie resistance. Knowledge of these processes provides a rational basis for developing therapeutic strategies to circumvent resistance.
Similar articles
-
Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy.Curr Pharm Des. 2016;22(44):6645-6664. doi: 10.2174/1381612822666160831101529. Curr Pharm Des. 2016. PMID: 27587202 Review.
-
Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues.Biochim Biophys Acta. 1997 Nov 20;1354(3):261-71. doi: 10.1016/s0167-4781(97)00087-0. Biochim Biophys Acta. 1997. PMID: 9427535
-
Cisplatin and platinum drugs at the molecular level. (Review).Oncol Rep. 2003 Nov-Dec;10(6):1663-82. Oncol Rep. 2003. PMID: 14534679 Review.
-
Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.Chem Biol Interact. 2004 Jun 30;148(1-2):37-48. doi: 10.1016/j.cbi.2004.04.002. Chem Biol Interact. 2004. PMID: 15223355
-
Novel approaches towards development of non-classical platinum-based antineoplastic agents: design of platinum complexes characterized by an alternative DNA-binding pattern and/or tumor-targeted cytotoxicity.Curr Med Chem. 2005;12(19):2177-91. doi: 10.2174/0929867054864877. Curr Med Chem. 2005. PMID: 16178779 Review.
Cited by
-
Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain.Sci Rep. 2016 Jan 13;6:19231. doi: 10.1038/srep19231. Sci Rep. 2016. PMID: 26757824 Free PMC article.
-
Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.J Neurosci. 2010 Mar 17;30(11):3933-46. doi: 10.1523/JNEUROSCI.6054-09.2010. J Neurosci. 2010. PMID: 20237264 Free PMC article.
-
Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein.Cancer Cell Int. 2004 Oct 19;4(1):6. doi: 10.1186/1475-2867-4-6. Cancer Cell Int. 2004. PMID: 15494073 Free PMC article.
-
Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.J Assoc Res Otolaryngol. 2007 Sep;8(3):338-55. doi: 10.1007/s10162-007-0084-9. Epub 2007 May 22. J Assoc Res Otolaryngol. 2007. PMID: 17516123 Free PMC article.
-
Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice.PLoS One. 2014 Jan 14;9(1):e86057. doi: 10.1371/journal.pone.0086057. eCollection 2014. PLoS One. 2014. PMID: 24454954 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources